세계의 혈액 분석기 시장 보고서(2025년)
Hematology Analyzers Global Market Report 2025
상품코드 : 1769611
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,430,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,294,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,159,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

혈액 분석기 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년 연간 평균 성장률(CAGR)은 6.9%로 성장할 전망이며, 53억 달러로 성장이 예측됩니다. 예측 기간의 성장은 만성질환 이환율 증가, 진단연구소 확대, 맞춤형 의료에 대한 수요 증대, 건강 의식 제고, 세계 인구의 고령화 등에 기인할 것으로 보입니다. 이 기간에 예상되는 주요 동향으로는 인공지능(AI) 및 기계학습 통합, 장치 소형화, 클라우드 기반 데이터 관리 시스템 채택, 자동화 및 로봇 공학 진보, 웨어러블 혈액학 모니터링 장치 출현 등이 있습니다.

혈액 질환의 이환율 증가는 향후 혈액 분석기의 성장을 가속할 것으로 예측됩니다. 혈액 질환은 적혈구, 백혈구, 혈소판, 혈장 등 혈액의 다양한 성분에 영향을 미치는 질환입니다. 이러한 증가는 혈액 건강에 영향을 미치고 지속적인 모니터링을 필요로 하는 만성 질환의 유병률 증가와 크게 관련되어 있습니다. 혈액 분석기는 혈액 성분의 정확하고 신속한 분석을 통해 이러한 질환의 진단을 지원하고 조기 발견과 치료를 가능하게 합니다. 더 나은 임상적 의사결정을 지원하고 환자 케어와 전귀의 개선으로 이어집니다. 예를 들어 2024년 4월 호주를 거점으로 하는 비영리단체 Perth Blood Institute는 혈우병(혈액응고장애와 장기간 출혈을 특징으로 하는 유전성 혈액질환)으로 진단된 사람의 수가 2021년 23만3,577명에서 2022년 25만 7,146명에 달했다고 보고했습니다. 이처럼 혈액 질환의 유병률 상승이 혈액 분석기 시장의 성장을 촉진하고 있습니다.

혈액 분석기 시장의 주요 기업은 진단 정밀도 향상, 워크플로우 효율화, 최소한의 수작업으로 신속한 검사 결과를 제공하기 위해 자동 혈액학 시스템 등의 기술적으로 선진적인 제품의 개발에 주력하고 있습니다. 자동 혈액 검사 시스템은 임상검사실에서 사용되는 고도의 진단장치로 사람의 손을 거의 거치지 않고 다양한 혈액학적 검사를 실시할 수 있습니다. 예를 들면, 2024년 1월, 일본의 의료 진단 회사인 호리바 메디컬은 HELO 2.0 하이 스루풋 자동 혈액학 플랫폼을 발표했습니다. HELO 2.0은 중규모에서 대규모 검사실용으로 유연성, 확장성, 효율성이 뛰어난 모듈식 솔루션을 제공합니다. HELO 2.0은 유미젠 H2500 및 H1500 분석기의 첨단 기술을 적용하여 360도 샘플 혼합, 최적화된 턴어라운드 타임, 공간 효율, 시약 보관 등의 우수한 성능을 보장합니다. 또한 ISO-15189 인증을 지원하여 분석 전, 분석, 분석 후의 모든 요건에 대응합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향 및 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석 및 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별 및 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도 및 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹 및 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문 및 전략

제36장 부록

AJY
영문 목차

영문목차

Hematology analyzers are automated laboratory devices designed to count and analyze blood cells, including red blood cells, white blood cells, and platelets. They are essential for diagnosing and monitoring medical conditions such as anemia, infections, clotting disorders, and blood cancers. The primary function of these analyzers is to deliver accurate, fast, and detailed blood test results to aid clinical decision-making.

There are two main types of hematology analyzers including fully automated and semi-automated. Fully automated hematology analyzers are sophisticated systems that conduct complete blood analyses with minimal manual input, handling tasks such as sample preparation, cell counting, and result interpretation automatically. These analyzers are composed of various components, including instruments, reagents, and consumables, and are available in two key modalities: standalone systems and point-of-care devices. They employ advanced technologies like flow cytometry, electrical impedance, and optical methods, serving end users such as hospitals, clinical laboratories, research institutions, and others.

The hematology analyzers market research report is one of a series of new reports from The Business Research Company that provides hematology analyzers market statistics, including the hematology analyzers industry global market size, regional shares, competitors with the hematology analyzers market share, detailed hematology analyzers market segments, market trends, and opportunities, and any further data you may need to thrive in the hematology analyzers industry. This hematology analyzers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The hematology analyzers market size has grown strongly in recent years. It will grow from $3.78 billion in 2024 to $4.05 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth during the historic period can be attributed to the increasing prevalence of blood disorders, a growing aging population, rising health awareness, improvements in healthcare infrastructure, and enhanced government support for health initiatives.

The hematology analyzers market size is expected to see strong growth in the next few years. It will grow to $5.30 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to the increasing incidence of chronic diseases, the expansion of diagnostic laboratories, rising demand for personalized medicine, growing health consciousness, and an aging global population. Key trends expected during this period include the integration of artificial intelligence (AI) and machine learning, device miniaturization, adoption of cloud-based data management systems, advancements in automation and robotics, and the emergence of wearable hematology monitoring devices.

The increasing incidence of blood disorders is expected to drive the growth of the hematology analyzers market in the future. Blood disorders are conditions that affect various components of the blood, such as red blood cells, white blood cells, platelets, or plasma. This rise is largely linked to the growing prevalence of chronic diseases that impact blood health and require continuous monitoring. Hematology analyzers assist in diagnosing these disorders by delivering precise and rapid analysis of blood components, allowing for early detection and treatment. They support better clinical decision-making, which leads to improved patient care and outcomes. For example, in April 2024, the Perth Blood Institute, an Australia-based non-profit organization, reported that the number of individuals diagnosed with hemophilia-a genetic blood disorder characterized by impaired clotting and prolonged bleeding-reached 257,146 in 2022, up from 233,577 in 2021. Thus, the rising prevalence of blood disorders is fueling the growth of the hematology analyzers market.

Leading companies in the hematology analyzers market are concentrating on developing technologically advanced products, such as automated hematology systems, to enhance diagnostic accuracy, improve workflow efficiency, and provide faster test results with minimal manual effort. Automated hematology systems are sophisticated diagnostic machines used in clinical laboratories to conduct a range of hematological tests with little human intervention. For example, in January 2024, Horiba Medical, a Japan-based medical diagnostics company, introduced the HELO 2.0 high-throughput automated hematology platform, which is approved under the Conformite Europeenne In Vitro Diagnostic Regulation (CE-IVDR) and is awaiting approval from the United States Food and Drug Administration (FDA). The HELO 2.0 delivers a flexible, scalable, and efficient modular solution tailored for mid- to large-scale laboratories. It incorporates advanced technologies from the Yumizen H2500 and H1500 analyzers, ensuring superior performance with 360-degree sample mixing, optimized turnaround time, space efficiency, and reagent storage. Additionally, it supports ISO-15189 accreditation, addressing all pre-analytical, analytical, and post-analytical requirements.

In June 2023, Mars Incorporated, a U.S.-based food company, acquired Heska Corporation for $1.3 billion. Through this acquisition, Mars intends to strengthen its position in the animal health diagnostics market, focusing especially on veterinary diagnostics, and to broaden its range of diagnostic solutions for veterinary professionals. Heska Corporation, also based in the U.S., specializes in veterinary diagnostics, including hematology analyzers.

Major players in the hematology analyzers market are F. Hoffmann-La Roche AG, Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Sysmex Corporation, Horiba Medical Ltd., Nihon Kohden Corporation, Trivitron Healthcare Pvt. Ltd., Transasia Bio-Medicals Ltd., Erba Mannheim GmbH, Boule Diagnostics AB, Diatron MI PLC, Awareness Technology Inc., Analyticon Biotechnologies AG, Rayto Life and Analytical Sciences Co. Ltd., Diagon Ltd., Perlong Medical, Drew Scientific Inc., and PZ Cormay S.A.

North America was the largest region in the hematology analyzers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in hematology analyzers report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the hematology analyzers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hematology analyzers market consists of sales of electrolyte analyzers, microplate readers, and diagnostic blood testing kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hematology Analyzers Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hematology analyzers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for hematology analyzers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hematology analyzers market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Hematology Analyzers Market Characteristics

3. Hematology Analyzers Market Trends And Strategies

4. Hematology Analyzers Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Hematology Analyzers Growth Analysis And Strategic Analysis Framework

6. Hematology Analyzers Market Segmentation

7. Hematology Analyzers Market Regional And Country Analysis

8. Asia-Pacific Hematology Analyzers Market

9. China Hematology Analyzers Market

10. India Hematology Analyzers Market

11. Japan Hematology Analyzers Market

12. Australia Hematology Analyzers Market

13. Indonesia Hematology Analyzers Market

14. South Korea Hematology Analyzers Market

15. Western Europe Hematology Analyzers Market

16. UK Hematology Analyzers Market

17. Germany Hematology Analyzers Market

18. France Hematology Analyzers Market

19. Italy Hematology Analyzers Market

20. Spain Hematology Analyzers Market

21. Eastern Europe Hematology Analyzers Market

22. Russia Hematology Analyzers Market

23. North America Hematology Analyzers Market

24. USA Hematology Analyzers Market

25. Canada Hematology Analyzers Market

26. South America Hematology Analyzers Market

27. Brazil Hematology Analyzers Market

28. Middle East Hematology Analyzers Market

29. Africa Hematology Analyzers Market

30. Hematology Analyzers Market Competitive Landscape And Company Profiles

31. Hematology Analyzers Market Other Major And Innovative Companies

32. Global Hematology Analyzers Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hematology Analyzers Market

34. Recent Developments In The Hematology Analyzers Market

35. Hematology Analyzers Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기